F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.
Hot Summer Threatens Efficacy of Mail-Order Medications

Hot Summer Threatens Efficacy of Mail-Order Medications

The temperatures inside delivery trucks can reach twice the recommended threshold, but federal rules on drug storage conditions do not apply to the booming world of mail-order delivery.